Medical device manufacturer, Brainlab, has issued a field safety notice advising users of a potential undesirable effect that might occur with the Pencil Beam Dose Algorithm of BrainSCAN version 5.31 or version 5.32 under specific conditions.
The BrainSCAN Pencil Beam Dose Algorithm may overestimate the dose delivered to the target region if both of the following conditions are met:
As a consequence, a dose lower than planned and intended might be delivered to the patient, potentially resulting in ineffective treatment.
According to the local supplier, the affected device has been distributed in Hong Kong. If you are in possession of the affected products, please contact supplier for necessary actions.